Efficacy of ivabradine, a new selective If inhibitor, compared with atenolol in patients with chronic stable angina
Author:
Publisher
Oxford University Press (OUP)
Subject
Cardiology and Cardiovascular Medicine
Link
http://academic.oup.com/eurheartj/article-pdf/26/23/2529/9625206/ehi586.pdf
Reference24 articles.
1. Guth BD, Heusch G, Seitelberger R, Ross J Jr. Mechanisms of beneficial effect of beta-adrenergic blockade on exercise-induced myocardial ischemia in conscious dogs. Circ Res1987;60:738–746.
2. North of England Stable Angina Guideline Development Group. Summary version of evidence based guideline for the primary care management of angina. Br Med J1996;312:827–832.
3. Ko DT, Hebert PR, Coffey CS, Sedrakyan A, Curtis JP, Krumholz HM. Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA2002;288:351–357.
4. Fogari R, Zoppi A, Corradi L, Mugellini A, Poletti L, Lusardi P. Sexual function in hypertensive males treated with lisinopril or atenolol: a cross-over study. Am J Hypertens1998;11:1244–1247.
5. Tafreshi MJ, Weinacher AB. Beta-adrenergic-blocking agents in bronchospastic diseases: a therapeutic dilemma. Pharmacotherapy1999;19:974–978.
Cited by 467 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. 2024 ESC Guidelines for the management of chronic coronary syndromes;European Heart Journal;2024-08-30
2. Feasibility of Short-Term Use of Ivabradine in Critical Ill Patients Who Have Atrial Fibrillation and Tachycardia;ACTA CARDIOL SIN;2024
3. Tablet Compression Optimization of Ivabradine Sustained-Release Tablet Using Full Factorial Design;Indian Journal of Pharmaceutical Education and Research;2024-06-21
4. Omecamtiv Mecarbil in the treatment of heart failure: the past, the present, and the future;Frontiers in Cardiovascular Medicine;2024-03-19
5. Ivabradine: sinus rhythm control in heart failure;Pathophysiology, Risk Factors, and Management of Chronic Heart Failure;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3